A private psilocybin program is supervised psychedelic-assisted work built around a single person rather than a group: psychiatric and medical screening before anything else, sessions only where they are lawful, a clinical team that is there for you alone, and months of structured integration afterward. At INLIBRIUM that means three seven-day residencies at a private site in Jamaica over six months, with no other clients present at any point.
Most of what is sold as psilocybin for executives is a group retreat: a week with strangers, a shared schedule, then a few follow-up calls. This page explains what changes when the work is built for one person, what screening a serious program should do, and how to judge any provider, including us.
What is a private psilocybin program?
It is psilocybin-assisted work in which the client is the only participant. Screening, preparation, the sessions and the integration that follows are planned around one person’s history, health and goals. In our program, three core experts — a psychiatrist or psychologist, a health expert and a leadership coach — stay with you for the full six months, and more specialists join during each residency.
How is it different from a group psilocybin retreat?
In a group, the schedule, the setting and often the pace are shared, and other participants learn your face, your story and why you came, without having signed anything. In a private program none of that applies. There is no group to keep pace with and no one present who is not bound by a non-disclosure agreement. And because there is no group, the days around each session are planned around you rather than around a shared schedule.
Is a private psilocybin program legal?
It depends entirely on where the sessions take place. Psilocybin is a controlled substance in most countries. Our residencies take place in Jamaica, where psilocybin has never been listed in the Dangerous Drugs Act, the law that defines the country’s drug offenses. That is a narrower statement than “legal” usually suggests, and your own country’s law still applies to you wherever you travel. Our Jamaica legal reference sets out exactly what the law says, and where psilocybin is legal covers ten jurisdictions.
What screening happens before you are accepted?
Two parts, both before any decision. Psychiatric screening: a questionnaire followed by an interview with a psychiatrist, to answer one question: is there anything in your history that makes a session likely to harm rather than help? Medical review: bloodwork, cardiovascular and renal markers, blood pressure, BMI, health history and every medication and supplement you take, reviewed with a nurse practitioner or physician. If the physician judges it necessary, you are referred for an EKG. Some people are declined at this stage. That is what the stage is for. The exclusions follow those used in FDA-regulated psilocybin trials: a personal or family history of schizophrenia-spectrum or psychotic disorders, bipolar I or II, serious cardiac or renal conditions, lithium and MAOIs. Antidepressants are not an automatic exclusion; each case is a clinical decision. The full criteria are on our safety and screening page.
Who is with you during a session?
Two trained facilitators are in the room for the whole of every session, not on call and not nearby. A dual board-certified nurse practitioner (FNP-BC and PMHNP-BC) is physically on site throughout the residency, including during every session, and a team of four to five experts is on site across the seven days. A local physician is available in Jamaica, our neurologist and clinical psychologist are reachable at all times, resuscitation equipment is kept on site, and a hospital in Montego Bay is about 10 km away.
How private is it, really?
One client per residency, no group, and every member of staff — the clinical team, the facilitators and the on-site staff — under a non-disclosure agreement that does not expire. Confidentiality is also written into the client contract. Nothing about a client is published without separate written consent, which can be withdrawn at any time. What we cannot control is what you tell people yourself; anyone promising absolute secrecy is overselling. More on our confidentiality page.
How long does it take?
Six months, in three phases. Each phase is built around one seven-day residency in Jamaica, with two psilocybin sessions per residency. Around them sit about 50 to 60 online one-to-one sessions with your three core experts, roughly two a week, designed to run alongside a working life. A full diagnostic panel is measured at the start and again at the end.
Who is it for, and who is it not for?
It is built for founders, CEOs and senior leaders who have reached the point where success stopped feeling like enough, and who want the work done properly rather than quickly. It is not for anyone looking for a weekend breakthrough, an escape, or the experience without the preparation and integration around it. We have written who this program is not for in full so you can rule yourself out quickly.
Private program or group retreat: what actually differs
A group format is not wrong for everyone. It is a different product. For a wider comparison, see retreat vs. clinical program.
Other participants
Group retreat: usually strangers. Ours: none. One client per residency.
Who has signed a non-disclosure agreement
Group retreat: staff, sometimes. Ours: every member of staff, and no other clients present.
Screening before acceptance
Group retreat: often a questionnaire. Ours: a psychiatric interview and a medical review of bloodwork, cardiovascular and renal markers and medications.
Medical presence during sessions
Group retreat: varies. Ours: a dual board-certified nurse practitioner on site throughout, and two facilitators in the room for the whole session.
Pace and schedule
Group retreat: shared with the group. Ours: planned around one person.
Length
Group retreat: about a week, then a few calls. Ours: six months, with three residencies and 50–60 online sessions.
Measurement
Group retreat: rarely. Ours: a full diagnostic panel at the start and again at the end.
What “one client at a time” changes
Privacy becomes structural.
The most common privacy failure in this category is other participants. With no group, the question disappears instead of depending on everyone’s discretion.
Decisions are made for one person.
There is no standardized protocol, path or dose. Preparation, the sessions and the integration plan follow your psychiatric and medical assessment, your diagnostic panel and your goals.
The team’s attention is not divided.
During a residency, the clinical team, the facilitators and the household are there for one client. The days around each session are spent on one-to-one work with your psychologist, health expert and coach, somatic practice such as yoga, breathwork, meditation and massage, and time in nature.
The return is planned.
A week of clarity tends to fade within a couple of months when nothing around it changes. Each residency is followed by weekly psychotherapy and health calls and coaching every second week, so that what surfaced turns into decisions at work and at home. More on why breakthroughs fade and what holds.
Six questions to ask any private program
Put these to any provider, including us. A serious program answers each one specifically, and in writing if you ask.
Who screens me, and what rules someone out?
Ours: a psychiatrist interviews you, and a medical review covers bloodwork, cardiovascular and renal markers and every medication.
Who is in the room, and for how long?
Ours: two trained facilitators for the whole of every session, and a dual board-certified nurse practitioner on site throughout the residency.
What happens in an emergency?
Ours: resuscitation equipment on site, a hospital in Montego Bay about 10 km away, and escalation pathways agreed before you arrive.
Under which law do the sessions take place?
Ours: Jamaica, where psilocybin has never been listed in the Dangerous Drugs Act.
Who else will be there, and who has signed what?
Ours: no other clients, and every member of staff under a non-disclosure agreement with no expiry.
What does integration consist of, and for how long?
Ours: six months, with 20–24 sessions with your psychiatrist or psychologist alone.
Who runs it
The clinical team includes a psychiatrist and neuroscientist (Alexander Lebedev, MD, PhD), a neurologist who leads medical screening (Burton J. Tabaac, MD, FAHA), a clinical psychologist and neuropsychologist (Sarah M. Henry, PhD), and a dual board-certified nurse practitioner (Lauren J. Marchefka, MSN, FNP-BC, PMHNP-BC). The program is led by co-founders Hardi Põder, CEO, and Monika Jakobson, Health & Science Director. Meet the whole team →
“We work with one person at a time — and that is not a figure of speech. Everything, from screening to the six months that follow, is built around a single individual, assessed as a whole human being by senior specialists in each field.”
Monika Jakobson, Co-founder, Health & Science Director
How to start
1. A private conversation. An unhurried call with the founders about where you are and what you are looking for. No pitch, no pressure. Pricing is discussed here.
2. The eligibility assessment. The psychiatric screening and medical review described above. Some people are declined.
3. Your program begins. Your testing panel and first sessions start online, and your first residency is scheduled.
Request a private conversation →
Nothing on this page is medical or legal advice. If any of the screening criteria apply to you, or you are unsure whether they do, speak to your own doctor before anything else.
What we assess before acceptance, what rules someone out, and what happens if something goes wrong.
How a six-month program differs from a retreat or executive coaching, including where our format is the wrong choice.
Ten jurisdictions, each with the legal mechanism that actually applies: never scheduled, prescription only, individual government authorization, or supervised access with no diagnosis at all. Including where our own residencies take place, and why.